Quick Search:       Advanced Search
Ultrasound image characteristic analysis of non-small cell lung cancer patients with supraclavicular lymph node metastasis before and after treatment with anlotinib
Received:February 23, 2020  Revised:March 30, 2020  Click here to download the full text
Citation of this paper:LIU Qi-zhi,QIANG Hui-ping,LEI Yu-qiong,CHEN Jie,FENG Hui,QIAN Jia-lin,ZHANG Yan-wei,CHU Tian-qing,WU Wei-hua.Ultrasound image characteristic analysis of non-small cell lung cancer patients with supraclavicular lymph node metastasis before and after treatment with anlotinib[J].Chinese Journal of Clinical Medicine,2020,27(3):410-413
Hits: 1979
Download times: 669
Author NameAffiliationE-mail
LIU Qi-zhi Department of Ultrasonography, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China  
QIANG Hui-ping Department of Ultrasonography, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China  
LEI Yu-qiong Department of Ultrasonography, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China  
CHEN Jie Department of Ultrasonography, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China  
FENG Hui Department of Ultrasonography, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China  
QIAN Jia-lin Department of Ultrasonography, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China  
ZHANG Yan-wei Department of Ultrasonography, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China  
CHU Tian-qing Department of Ultrasonography, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China ctqxkyy@163.com 
WU Wei-hua Department of Ultrasonography, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China liu987@vip.sina.com 
Abstract:Objective: To analyze the blood flow characteristics of the supraclavicular lymph nodes metastasis in patients with advanced non-small cell lung cancer by color Doppler ultrasound, these patients were treated with anlotinib as an anti-angiogenic drug, and therefore to provide help for lung cancer patients to evaluate the curative effect of the drug. Methods: From February 2019 to November 2019, clinical data of 31 advanced non-small cell lung cancer patients in the Chest Hospital, Shanghai Jiao Tong University treated with anlotinib were analyzed retrospectively. The two-dimensional color Doppler ultrasonography characteristics of the metastatic lymph nodes on the clavicle before and after two cycles of anlotinib treatment were compared and the correlation was analyzed. Results: The peak systolic velocity (PSV) of supraclavicular lymph node blood flow in patients after the treatment with anlotinib decreased significantly (12.8 cm/s vs 7.5 cm/s), and the difference was statistically significant (P=0.006). Before the treatment, the blood flow classification of supraclavicular lymph nodes in patients with anlotinib was 38.7%, 12.1%, 18.2% and 29.0% in patients with level 3.1% and 41.9% in patients with level 0, and the difference was statistically significant (P=0.029). Before the treatment, 29.0% of the patients had no blood flow distribution in supraclavicular lymph nodes, and 19.4%, 3.2% and 48.4% in central, marginal, and mixed types, respectively. After treatment with anlotinib the proportion of mixed blood flow pattern in supraclavicular lymph nodes decreased to 22.6%(P=0.001) and that of non-blood flow pattern increased to 41.9%. Conclusions: As an antiangiogenic drug, anlotinib has a direct and effective effect on the blood flow of metastatic supraclavicular lymph nodes. The changes of the size and blood flow characteristics of supraclavicular lymph nodes can be used as a criterion for the short-term efficacy of ultrasound in the diagnosis of lung cancer.
keywords:ultrasound  lung cancer  supraclavicular lymph nodes
HTML  View Full Text  View/Add Comment  Download reader